These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7951167)
1. Effect of contraceptive steroid and enalapril treatment of systolic blood pressure and plasma renin-angiotensin in the rat. Byrne KB; Geraghty DP; Stewart BJ; Burcher E Clin Exp Hypertens; 1994 Sep; 16(5):627-57. PubMed ID: 7951167 [TBL] [Abstract][Full Text] [Related]
2. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
4. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
5. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition. Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557 [TBL] [Abstract][Full Text] [Related]
6. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207 [TBL] [Abstract][Full Text] [Related]
7. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
8. Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats. Geraghty DP; Byrne KB; McPherson GA; Burcher E Clin Exp Pharmacol Physiol; 1990 Aug; 17(8):567-78. PubMed ID: 2170069 [TBL] [Abstract][Full Text] [Related]
9. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [TBL] [Abstract][Full Text] [Related]
10. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways. Witte K; Huser L; Knotter B; Heckmann M; Schiffer S; Lemmer B Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):101-9. PubMed ID: 11191827 [TBL] [Abstract][Full Text] [Related]
11. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Richer C; Bruneval P; Ménard J; Giudicelli JF Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242 [TBL] [Abstract][Full Text] [Related]
12. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450 [TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Nussberger J; Wuerzner G; Jensen C; Brunner HR Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102 [TBL] [Abstract][Full Text] [Related]
15. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
17. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women. Straznicky NE; Barrington VE; Branley P; Louis WJ J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929 [TBL] [Abstract][Full Text] [Related]
18. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients]. Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035 [TBL] [Abstract][Full Text] [Related]